Copy Link Print Information

Doramapimod

(Synonyms: BIRB 796)
52 Cited Publications
Avis client

Based on 52 publication(s) in Google Scholar

Doramapimod (BIRB 796) is an orally active, highly potent p38 MAPK inhibitor, which has an IC50 for p38α=38 nM, for p38β=65 nM, for p38γ=200 nM, and for p38δ=520 nM. Doramapimod has picomolar affinity for p38 kinase (Kd=0.1 nM). Doramapimod also inhibits B-Raf with an IC50 of 83 nM.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté: 99.93%
  • CAS No.: 285983-48-4
  • Formule: C31H37N5O3
  • Masse moléculaire:527.66
  • Stockage:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 1 year , -20°C, 6 months
  • Doramapimod Chemical Structure
    Doramapimod Chemical Structure
  • Experimental Validation Results for Doramapimod
  • Experimental Validation Results for Doramapimod
  • Experimental Validation Results for Doramapimod
  • Experimental Validation Results for Doramapimod
  • Experimental Validation Results for Doramapimod
CAS No.: 285983-48-4
Size
Prix
Stock
Quantité
Amount: USD 0.00
Please select quantity
or
or

* Veuillez sélectionner la quantité avant d'ajouter des articles.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Doramapimod:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Trouvez votre distributeur local Your local distributor: Hycultec GmbHHycultec
  • Activité biologique
  • Chemical Information
  • Solvant et solubilité
  • Protocole
  • Pureté et documentation
  • Références
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Doramapimod

More
Customer Validation & Images
IP2D/3D Cell Culture and DifferentiationWBIF
  • WB
  • WB
  • IF
  • 2D/3D Cell Culture and Differentiation
  • IP

Voir tous les produits spécifiques à Isoform p38 MAPK

More

Voir tous les produits spécifiques à Isoform Raf

More
Keywords
MOQ
Minimum order quantity
100 mg

Obtenir un devis En stock

Other size
Obtenir un devis
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Enregistrer
Sign in to MedChemExpress
Enregistrer un nouveau compte

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Doramapimod Chemical Structure
    Doramapimod Chemical Structure
    1/16
  • 1/16

    Doramapimod purchased from MedChemExpress. Usage Cited in: Engineering. 2025 Mar 4.

    Customer Validation
     BIRB 796 (10 μM, 36 h) inhibited the expression of p-p38 MAPK induced by LPS (200 ng/mL) in THP-1 cells.

  • 1/16

    Doramapimod purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Sep 6:76:103344. [Abstract]

    Customer Validation
     BIRB 796 (DORA, 10 μM, 4 h) inhibited the expression of p-p38 MAPK induced by LPS (1000 ng/mL) in 10T1/2 cells.

  • 1/16

    Doramapimod purchased from MedChemExpress. Usage Cited in: Redox Biol. 2024 Sep 6:76:103344. [Abstract]

    Customer Validation
     BIRB 796 (DORA, 10 μM, 4 h) inhibited the mitochondrial recruitment of DRP1 and the fission induced by LPS (1000 ng/mL) in 10T1/2 cells.

  • 1/16

    Doramapimod purchased from MedChemExpress. Usage Cited in: Cell Res. 2020 Jul;30(7):574-589. [Abstract]

    Customer Validation
     Birb 796 (0.1, 0.3, 1, and 3 μM, 3 days) impaired the ability of SSK1 (0.5 μM,3 days) to specifically kill senescent HUVEC.

  • 1/16

    Doramapimod purchased from MedChemExpress. Usage Cited in: Nature. 2019 Jul;571(7763):127-131. [Abstract]

    Customer Validation
     BIRB 796 (1 μM, 4.5 h) did not abrogate EGF-induced pUGDH in A549 cells stably expressing Flag–UGDH.

  • Doramapimod